15 results
39 - The Role of Professional Associations and Patient Advocacy in Advancing Alzheimer’s Drug Development
- from Section 5 - Academic Drug-Development Programs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 449-454
-
- Chapter
- Export citation
PW01-25 - Extended Release Quetiapine Fumarate (quetiapine XR) In Patients With MDD: Results From 8 Placebo-controlled Studies
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1427
-
- Article
-
- You have access
- Export citation
Efficacy and tolerability of quetiapine XR 400/600/800mg/day in acute schizophrenia: a post-hoc analysis of data from two pooled randomised studies
-
- Journal:
- European Psychiatry / Volume 26 / Issue S2 / March 2011
- Published online by Cambridge University Press:
- 16 April 2020, p. 1411
-
- Article
-
- You have access
- Export citation
Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
-
- Journal:
- CNS Spectrums / Volume 18 / Issue 1 / February 2013
- Published online by Cambridge University Press:
- 14 January 2013, pp. 43-54
-
- Article
- Export citation
Essential CNS Drug Development - Title page
-
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp iii-iii
-
- Chapter
- Export citation
Contents
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp v-v
-
- Chapter
- Export citation
Index
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp 200-207
-
- Chapter
- Export citation
Essential CNS Drug Development - Half title page
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp i-ii
-
- Chapter
- Export citation
Contributors
-
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp vi-viii
-
- Chapter
- Export citation
Chapter 6 - CNS drug development – Phase III
-
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp 92-99
-
- Chapter
- Export citation
Essential CNS Drug Development
-
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012
Chapter 13 - Leveraging disruptive technologies to drive innovation in CNS clinical drug development
-
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp 192-199
-
- Chapter
- Export citation
Copyright page
-
- Book:
- Essential CNS Drug Development
- Published online:
- 05 July 2012
- Print publication:
- 07 June 2012, pp iv-iv
-
- Chapter
- Export citation
Culture and assessment of manic symptoms
-
- Journal:
- The British Journal of Psychiatry / Volume 189 / Issue 4 / October 2006
- Published online by Cambridge University Press:
- 02 January 2018, pp. 379-380
- Print publication:
- October 2006
-
- Article
-
- You have access
- HTML
- Export citation
The use of clozapine
-
- Journal:
- Psychiatric Bulletin / Volume 19 / Issue 9 / September 1995
- Published online by Cambridge University Press:
- 02 January 2018, p. 576
- Print publication:
- September 1995
-
- Article
-
- You have access
- Open access
- Export citation